Published in Malar J on April 18, 2008
Factors associated with use and non-use of mosquito nets owned in Oromia and Amhara regional states, Ethiopia. Malar J (2009) 3.66
Household possession and use of insecticide-treated mosquito nets in Sierra Leone 6 months after a national mass-distribution campaign. PLoS One (2012) 1.94
Predictors of mosquito net use in Ghana. Malar J (2011) 1.41
Determinants of bed net use in children under five and household bed net ownership on Bioko Island, Equatorial Guinea. Malar J (2011) 1.34
A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in Gabon. PLoS One (2009) 1.31
Social and cultural aspects of 'malaria' and its control in central Côte d'Ivoire. Malar J (2008) 1.29
Factors associated with coverage and usage of long-lasting insecticidal nets in madagascar. J Trop Med (2010) 1.09
Malaria knowledge and long-lasting insecticidal net use in rural communities of central Côte d'Ivoire. Malar J (2011) 1.06
Ownership and use of long-lasting insecticidal nets for malaria prevention in Butajira area, south-central Ethiopia: complex samples data analysis. BMC Public Health (2014) 0.96
Perceptions, health care seeking behaviour and implementation of a tuberculosis control programme in Lambaréné, Gabon. Public Health Action (2013) 0.91
Transmission of malaria in relation to distribution and coverage of long-lasting insecticidal nets in central Côte d'Ivoire. Malar J (2014) 0.87
Social economic factors and malaria transmission in Lower Moshi, northern Tanzania. Parasit Vectors (2012) 0.86
Prevalence of asymptomatic malaria and bed net ownership and use in Bhutan, 2013: a country earmarked for malaria elimination. Malar J (2014) 0.83
Factors associated with the non-use of insecticide-treated nets in Rwandan children. Malar J (2016) 0.80
Child bed net use before, during, and after a bed net distribution campaign in Bo, Sierra Leone. Malar J (2015) 0.75
Field Evaluation of the Bio-Efficacy of Three Pyrethroid Based Coils against Wild Populations of Anthropophilic Mosquitoes in Northern Tanzania. J Glob Infect Dis (2010) 0.75
Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev (2004) 28.04
Constructing socio-economic status indices: how to use principal components analysis. Health Policy Plan (2006) 18.72
Monitoring mosquito net coverage for malaria control in Africa: possession vs. use by children under 5 years. Trop Med Int Health (2003) 4.29
Integrating insecticide-treated bednets into a measles vaccination campaign achieves high, rapid and equitable coverage with direct and voucher-based methods. Trop Med Int Health (2005) 3.57
Mosquito nets and the poor: can social marketing redress inequities in access? Trop Med Int Health (2004) 2.44
Which delivery systems reach the poor? A review of equity of coverage of ever-treated nets, never-treated nets, and immunisation to reduce child mortality in Africa. Lancet Infect Dis (2005) 2.39
Wealth, mother's education and physical access as determinants of retail sector net use in rural Kenya. Malar J (2006) 2.37
Evaluation of long-lasting insecticidal nets after 2 years of household use. Trop Med Int Health (2005) 2.33
No influence of socioeconomic factors on severe malarial anaemia, hyperparasitaemia or reinfection. Trans R Soc Trop Med Hyg (1999) 2.01
Effects of malaria during pregnancy on infant mortality in an area of low malaria transmission. Am J Epidemiol (2001) 2.01
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial. J Infect Dis (2007) 1.99
Insecticide-treated nets. Adv Parasitol (2006) 1.97
Evaluation of KO-Tab 1-2-3: a wash-resistant 'dip-it-yourself' insecticide formulation for long-lasting treatment of mosquito nets. Malar J (2005) 1.92
Laboratory wash resistance of long-lasting insecticidal nets. Trop Med Int Health (2005) 1.90
Malaria epidemiology in the province of Moyen Ogoov, Gabon. Trop Med Parasitol (1995) 1.85
Socio-economic risk factors for malaria in a peri-urban area of The Gambia. Trans R Soc Trop Med Hyg (1995) 1.83
Interpreting household survey data intended to measure insecticide-treated bednet coverage: results from two surveys in Eritrea. Malar J (2006) 1.72
Factors influencing the use of bed nets in Mbarara municipality of Uganda. Am J Trop Med Hyg (2001) 1.59
Assessing household wealth in health studies in developing countries: a comparison of participatory wealth ranking and survey techniques from rural South Africa. Emerg Themes Epidemiol (2007) 1.59
The Gambian National Impregnated Bednet Programme: costs, consequences and net cost-effectiveness. Soc Sci Med (1998) 1.40
Socio-economic determinants are not major risk factors for severe malaria in Gambian children. Trans R Soc Trop Med Hyg (1995) 1.29
Who buys insecticide-treated nets? Implications for increasing coverage in Nigeria. Health Policy Plan (2003) 1.14
Prevention of malaria using ITNs: potential for achieving the millennium development goals. Curr Mol Med (2006) 1.07
Cerebral malaria in African children: socioeconomic risk factors in Brazzaville, Congo. Am J Trop Med Hyg (1994) 1.07
Equity in resource allocation for health: a comparative study of the Ashanti and Northern Regions of Ghana. Health Policy (2006) 1.02
Should governments subsidize the use of insecticide-impregnated mosquito nets in Africa? Implications of a cost-effectiveness analysis. Health Policy Plan (1997) 0.99
Plasmodium falciparum transmission intensity and infection rates in children in Gabon. Parasitol Res (2001) 0.98
Maternal use of insecticide-treated nets in the prevention of malaria among children under five years in Nyamira district, Kenya. East Afr Med J (2005) 0.88
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64
Allergy, parasites, and the hygiene hypothesis. Science (2002) 5.01
Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study. Lancet (2010) 4.95
Multidrug-resistant tuberculosis and culture conversion with bedaquiline. N Engl J Med (2014) 4.95
Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial. Lancet Infect Dis (2013) 3.46
Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Med (2009) 3.38
Short report: Piloting paperless data entry for clinical research in Africa. Am J Trop Med Hyg (2005) 2.85
Placental malaria increases malaria risk in the first 30 months of life. Clin Infect Dis (2008) 2.69
Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon. J Infect Dis (2005) 2.58
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. Lancet Infect Dis (2011) 2.54
Severe falciparum malaria in Gabonese children: clinical and laboratory features. Malar J (2005) 2.35
Haemozoin: from melatonin pigment to drug target, diagnostic tool, and immune modulator. Lancet Infect Dis (2007) 2.29
How useful is PCR in the diagnosis of malaria? Trends Parasitol (2002) 2.16
Fosmidomycin for malaria. Lancet (2002) 2.03
Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe. J Infect Dis (2004) 1.99
High prevalence of asymptomatic Plasmodium falciparum infection in Gabonese adults. Am J Trop Med Hyg (2007) 1.99
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial. J Infect Dis (2007) 1.99
Cystic echinococcosis in sub-Saharan Africa. Lancet Infect Dis (2012) 1.91
Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J Infect Dis (2012) 1.89
Microscopic and sub-microscopic Plasmodium falciparum infection, but not inflammation caused by infection, is associated with low birth weight. Am J Trop Med Hyg (2006) 1.88
Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren. J Infect Dis (2004) 1.85
Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam. Hepatology (2006) 1.82
Acute muscular sarcocystosis: an international investigation among ill travelers returning from Tioman Island, Malaysia, 2011-2012. Clin Infect Dis (2014) 1.80
Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon. J Infect Dis (2008) 1.70
Influenza in Africa. PLoS Med (2009) 1.68
Import and spread of Panton-Valentine Leukocidin-positive Staphylococcus aureus through nasal carriage and skin infections in travelers returning from the tropics and subtropics. Clin Infect Dis (2011) 1.67
Increased specific T cell cytokine responses in patients with active pulmonary tuberculosis from Central Africa. Microbes Infect (2005) 1.63
Depressed natural killer cell cytotoxicity against Plasmodium falciparum-infected erythrocytes during first pregnancies. Clin Infect Dis (2004) 1.61
Management of imported malaria in Europe. Malar J (2012) 1.60
Intramuscular bioavailability and clinical efficacy of artesunate in gabonese children with severe malaria. Antimicrob Agents Chemother (2002) 1.59
Increased prevalence of intestinal helminth infection during pregnancy in a Sub-Saharan African community. Wien Klin Wochenschr (2007) 1.58
Does treatment of intestinal helminth infections influence malaria? Background and methodology of a longitudinal study of clinical, parasitological and immunological parameters in Nangapanda, Flores, Indonesia (ImmunoSPIN Study). BMC Infect Dis (2010) 1.57
Impact of increasing consultation fees on malaria in Africa. Wien Klin Wochenschr (2004) 1.56
History and perspectives of medical research at the Albert Schweitzer Hospital in Lambaréné, Gabon. Wien Klin Wochenschr (2007) 1.52
Assessment of volume depletion in children with malaria. PLoS Med (2004) 1.51
Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity. J Infect Dis (2008) 1.51
Local and International Implications of Schistosomiasis Acquired in Corsica, France. Emerg Infect Dis (2015) 1.45
Adolescence as risk factor for adverse pregnancy outcome in Central Africa--a cross-sectional study. PLoS One (2010) 1.43
Effectiveness of rifaximin in prevention of diarrhoea in individuals travelling to south and southeast Asia: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Infect Dis (2013) 1.41
Evidence of decline of malaria in the general hospital of Libreville, Gabon from 2000 to 2008. Malar J (2009) 1.40
Reduced cord blood immune effector-cell responsiveness mediated by CD4+ cells induced in utero as a consequence of placental Plasmodium falciparum infection. J Infect Dis (2005) 1.40
Plasmodium falciparum activates endogenous Cl(-) channels of human erythrocytes by membrane oxidation. EMBO J (2002) 1.40
Dengue virus infection in travellers returning to Berlin, Germany: clinical, laboratory, and diagnostic aspects. Acta Trop (2004) 1.39
Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine. Malar J (2011) 1.38
Differential regulation of beta-chemokines in children with Plasmodium falciparum malaria. Infect Immun (2005) 1.37
Clindamycin as an antimalarial drug: review of clinical trials. Antimicrob Agents Chemother (2002) 1.36
Elevated nitric oxide production in children with malarial anemia: hemozoin-induced nitric oxide synthase type 2 transcripts and nitric oxide in blood mononuclear cells. Infect Immun (2004) 1.35
Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria. Antimicrob Agents Chemother (2006) 1.35
Malaria incidence in Limpopo Province, South Africa, 1998-2007. Malar J (2008) 1.35
Typhoid fever among children, Ghana. Emerg Infect Dis (2010) 1.35
Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African children. J Infect Dis (2004) 1.35
Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria. J Infect Dis (2004) 1.34
Malaria in pregnancy before and after the implementation of a national IPTp program in Gabon. Am J Trop Med Hyg (2007) 1.34
A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in Gabon. PLoS One (2009) 1.31
Submicroscopic Plasmodium falciparum infections and multiplicity of infection in matched peripheral, placental and umbilical cord blood samples from Gabonese women. Trop Med Int Health (2004) 1.29
Recognition of variant Rifin antigens by human antibodies induced during natural Plasmodium falciparum infections. Infect Immun (2002) 1.27
Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon. Malar J (2008) 1.27
Community response to intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in five African settings. Malar J (2009) 1.26
Automated haematology analysis to diagnose malaria. Malar J (2010) 1.25